Abu Ghosh Zahi, Amir Offer, Carasso Shemy, Planer David, Alcalai Ronny, Golomb Mordechai, Dagan Gil, Kalmanovich Eran, Blatt Alex, Elbaz-Greener Gabby
Department of Cardiology, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9190501, Israel.
The Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Safed 5290002, Israel.
J Clin Med. 2023 Mar 30;12(7):2603. doi: 10.3390/jcm12072603.
: Cardiogenic shock (CS) continues to be a severe and fatal complication of acute coronary syndrome (ACS). CS patients have a high mortality rate despite significant progress in primary reperfusion, the management of heart failure and the expansion of mechanical circulatory support strategies. The present study addressed the clinical characteristics, management, and outcomes of ACS patients complicated with CS. We performed an observational study, using the 2000-2013 Acute Coronary Syndrome Israeli Surveys (ACSIS) database and identified hospitalizations of ACS patients complicated with CS. Patients' demographics and clinical characteristics, complications and outcomes were evaluated. We assessed the outcomes of ACS patients with CS at arrival (on the day of admission) compared with ACS patients who arrived without CS and developed CS during hospitalization. The cohort included 13,434 patients with ACS diagnoses during the study period. Of these, 4.2% were complicated with CS; 224 patients were admitted with both ACS and CS; while 341 ACS patients developed CS only during the hospitalization period. The latter patients had significantly higher rates of MACEs compared with the group of ACS patients who presented with CS at arrival (73% vs. 51%; < 0.0001). Similarly, the rates of in-hospital mortality (55% vs. 36%; < 0.0001), 30-day mortality (64% vs. 50%; = 0.0013) and 1-year mortality (73% vs. 59%; = 0.0016) were higher in ACS patients who developed CS during hospitalization vs. ACS patients with CS at admission. There was a significant decrease in 1-year mortality trends during the 13 years of this study presented in ACS patients from both groups. Patients who developed CS during hospitalization had higher mortality and MACE rates compared with those who presented with CS at arrival. Further studies should focus on this subgroup of high-risk patients.
心源性休克(CS)仍然是急性冠状动脉综合征(ACS)的一种严重且致命的并发症。尽管在初级再灌注、心力衰竭管理以及机械循环支持策略扩展方面取得了显著进展,但CS患者的死亡率仍然很高。本研究探讨了合并CS的ACS患者的临床特征、管理及预后。我们进行了一项观察性研究,使用2000 - 2013年以色列急性冠状动脉综合征调查(ACSIS)数据库,确定合并CS的ACS患者的住院情况。评估了患者的人口统计学和临床特征、并发症及预后。我们比较了入院时(入院当天)合并CS的ACS患者与未合并CS但住院期间发生CS的ACS患者的预后。该队列包括研究期间13434例诊断为ACS的患者。其中,4.2%合并CS;224例患者同时患有ACS和CS;而341例ACS患者仅在住院期间发生CS。与入院时即合并CS的ACS患者组相比,后一组患者发生主要不良心血管事件(MACE)的比率显著更高(73%对51%;P<0.0001)。同样,住院期间发生CS的ACS患者的院内死亡率(55%对36%;P<0.0001)、30天死亡率(64%对50%;P = 0.0013)和1年死亡率(73%对59%;P = 0.0016)高于入院时即合并CS的ACS患者。在本研究的13年中,两组ACS患者的1年死亡率趋势均有显著下降。与入院时即合并CS的患者相比,住院期间发生CS的患者死亡率和MACE发生率更高。进一步的研究应关注这一高危患者亚组。